welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Safety Study of Flavocoxid in Duchenne Muscular Dystrophy

key information

study id #: NCT01335295

condition: Duchenne Muscular Dystrophy

status: completed


Objective of this study is to evaluate safety and tolerability of flavocoxid administered at the daily oral dose of 500 or 1000 mg/die for one year in DMD patients, alone or in association with steroids (deflazacort on alternate days) started at least one year before. The investigators will also perform a multidimensional clinical evaluation covering functional and muscle strength and quality of life (QoL)assessments.

intervention: Flavocoxid

mechanism of action: Antioxidant to reduce inflammation

results: https://clinicaltrials.gov/ct2/show/results/NCT01335295

last updated: November 21, 2018